NCT01035177

Brief Summary

Numerous geometric and bone mineral density (BMD) parameters can be derived from quantitative computed tomography (QCT) images of the proximal femur analyzed using dedicated software. The primary objective is to evaluate the contribution of QCT-image analysis to the prediction of the osteoporotic hip fracture risk, as compared to the reference standard, namely, dual energy X-ray absorptiometry (DXA). Study hypothesis: For predicting osteoporotic hip fracture, findings from QCT images of the proximal femur analyzed using dedicated software are superior over DXA measurements of proximal femoral BMD.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
107

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2005

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2005

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2008

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2009

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

December 17, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 18, 2009

Completed
Last Updated

December 18, 2009

Status Verified

March 1, 2008

Enrollment Period

3.1 years

First QC Date

December 17, 2009

Last Update Submit

December 17, 2009

Conditions

Keywords

Bone Mineral Density (BMD);Cortical bone;Hip fracture;Osteoporosis;Quantitative Computed Tomography (QCT).

Outcome Measures

Primary Outcomes (1)

  • The primary objective is to evaluate the contribution of QCT-image analysis to the prediction of the osteoporotic PFF risk, as compared to the reference standard, namely, DXA.

    1 month

Secondary Outcomes (3)

  • To compare the value of BMD parameters and geometric parameters in predicting osteoporotic PFFs

    1 month

  • To compare the roles for cortical bone and trabecular bone in predicting osteoporotic PFFs

    1 month

  • To look for differences between cervical and trochanteric hip fractures

    1 month

Study Arms (2)

Control

Women without hip fracture, matched on age to the cases

Patient

Female patients aged 60 and older with hip fracture

Eligibility Criteria

Age60 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women with a history of osteoporotic hip fracture (cases) will be recruited while hospitalized in one of the study centres for immediate care of their fracture. Women without osteoporotic fractures (controls) matched on age to the cases will be recruited while receiving outpatient or inpatient care at one of the study centres. Inclusion and exclusion criteria are detailed below

You may qualify if:

  • Selection of cases: women with hip fracture
  • woman aged 60 years and more
  • clinical suspicion of osteoporosis based on the following: trivial trauma (fall from the standing position), history of vertebral fracture or visualization of a vertebral fracture by CT
  • availability of radiographs of the proximal femur (anteroposterior view of the pelvis mandatory; anteroposterior and lateral views of the fractured hip optional)
  • signature by the patient of the informed consent document

You may not qualify if:

  • patient under 60 years
  • current bisphosphonate, oestrogen, or SERM treatment started more than 3 months earlier; or past treatment with these medications stopped less than 6 months earlier
  • hip arthroplasty on the other side
  • fracture at the site of a bone lesion
  • psychiatric disorder that might prevent the patient from giving informed consent or from remaining completely still for about 15 minutes during the investigations
  • informed consent document not signed by the patient
  • Selection of controls:
  • The controls will be women without hip fracture matched on age to the cases.
  • woman aged 60 years and more
  • signature by the patient of the informed consent document
  • age under 60 years
  • male
  • current bisphosphonate, oestrogen, or SERM therapy started more than 3 months earlier; or past treatment with these medications stopped less than 6 months earlier
  • history of osteoporotic hip fracture.
  • psychiatric disorder that might prevent the patient from giving informed consent or from remaining completely still for about 15 minutes during the investigations
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Lariboisière - APHP

Paris, 75010, France

Location

MeSH Terms

Conditions

OsteoporosisProximal Femoral FracturesHip Fractures

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesFemoral Neck FracturesFemoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Officials

  • Valérie BOUSSON, PH

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 17, 2009

First Posted

December 18, 2009

Study Start

February 1, 2005

Primary Completion

March 1, 2008

Study Completion

March 1, 2009

Last Updated

December 18, 2009

Record last verified: 2008-03

Locations